Nexera Technologies Ltd Warrant
NEXRW
8 hedge funds and large institutions have $109K invested in Nexera Technologies Ltd Warrant in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.
14% more funds holding
Funds holding: 7 → 8 (+1)
30.01% less ownership
Funds ownership: 30.01% → 0% (-30%)
33% less capital invested
Capital invested by funds: $163K → $109K (-$54.3K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$29 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$6 |
| 3 |
CS
Clear Street
New York
|
-$3 |
NEXRW Hedge Fund Activity: Q3 2025 in Review
8 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Nexera Technologies Ltd Warrant (NEXRW) for Q3 2025, worth a combined $109K — down 33% from $163K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NEXRW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.11K. The largest seller was UBS Group, cutting an estimated $29.
- 8 institutional investors held Nexera Technologies Ltd Warrant (NEXRW) as of Q3 2025, up from 7 in Q2 2025.
- Funds reported $109K of Nexera Technologies Ltd Warrant stock for Q3 2025, down 33% quarter-over-quarter.
- 1 fund opened new Nexera Technologies Ltd Warrant positions in Q3 2025 and 0 closed out, a net change of +1 holder.
- The largest Nexera Technologies Ltd Warrant buyer in Q3 2025 was Susquehanna International Group, an estimated $1.11K added.
- The largest Nexera Technologies Ltd Warrant seller in Q3 2025 was UBS Group, an estimated $29 sold.
Based on aggregated 13F filings for Q3 2025.